GHK-Cu, PRDX6 and Experimental Silicosis: Study Summary
Researchers studied GHK-Cu in a crystalline-silica mouse model and in cultured macrophages to examine oxidative stress, inflammation and fibrosis-related outcomes.
Study design
The team established an experimental silicosis model in mice and used RAW264.7 macrophage-line experiments. Target-identification work examined the proposed interaction between GHK-Cu and peroxiredoxin 6.
What the researchers reported
The paper reported reduced lung inflammation and fibrosis measures in mice and lower silica-induced oxidative stress in macrophages. The authors identified PRDX6 as a molecular target associated with these observations.
What this result does not establish
Mouse disease models and immortalised cell lines do not reproduce the full human condition. The study does not establish clinical efficacy, human exposure requirements or long-term safety.
This article summarizes one published study about GHK-Cu. It does not establish clinical efficacy, general safety, regulatory approval or suitability for human use. Findings should be interpreted within the model, methods and limitations of the original paper.
Related research material
Review the corresponding catalogue listing, labelled amount and available documentation. The study may use a different formulation or experimental preparation; it does not verify our product, its batch or suitability for human use.
Our Approach
Evidence before assumption.
TAM Global Research focuses on transparent documentation, careful scientific interpretation and clear distinction between what available evidence supports and what requires further verification.
Explore our quality standards